nodes	percent_of_prediction	percent_of_DWPC	metapath
Allopurinol—XDH—Carboplatin—urinary bladder cancer	0.17	0.238	CbGbCtD
Allopurinol—XDH—Cisplatin—urinary bladder cancer	0.145	0.203	CbGbCtD
Allopurinol—AOX1—Methotrexate—urinary bladder cancer	0.109	0.152	CbGbCtD
Allopurinol—SLC22A7—Fluorouracil—urinary bladder cancer	0.103	0.144	CbGbCtD
Allopurinol—XDH—Doxorubicin—urinary bladder cancer	0.0975	0.136	CbGbCtD
Allopurinol—SLC22A7—Methotrexate—urinary bladder cancer	0.0568	0.0792	CbGbCtD
Allopurinol—SLC22A8—Methotrexate—urinary bladder cancer	0.0347	0.0484	CbGbCtD
Allopurinol—SLC22A8—urine—urinary bladder cancer	0.00641	0.167	CbGeAlD
Allopurinol—XDH—prostate gland—urinary bladder cancer	0.00452	0.118	CbGeAlD
Allopurinol—XDH—renal system—urinary bladder cancer	0.00308	0.0803	CbGeAlD
Allopurinol—AOX1—prostate gland—urinary bladder cancer	0.00287	0.0748	CbGeAlD
Allopurinol—SLC22A7—renal system—urinary bladder cancer	0.00271	0.0707	CbGeAlD
Allopurinol—XDH—female reproductive system—urinary bladder cancer	0.00247	0.0643	CbGeAlD
Allopurinol—AOX1—seminal vesicle—urinary bladder cancer	0.00243	0.0633	CbGeAlD
Allopurinol—SLC22A8—prostate gland—urinary bladder cancer	0.0023	0.06	CbGeAlD
Allopurinol—XDH—vagina—urinary bladder cancer	0.00223	0.0581	CbGeAlD
Allopurinol—AOX1—renal system—urinary bladder cancer	0.00196	0.051	CbGeAlD
Allopurinol—AOX1—urethra—urinary bladder cancer	0.00192	0.0501	CbGeAlD
Allopurinol—SLC22A8—renal system—urinary bladder cancer	0.00157	0.0409	CbGeAlD
Allopurinol—AOX1—female reproductive system—urinary bladder cancer	0.00157	0.0409	CbGeAlD
Allopurinol—AOX1—vagina—urinary bladder cancer	0.00142	0.037	CbGeAlD
Allopurinol—XDH—Purine catabolism—GPX1—urinary bladder cancer	0.0013	0.0717	CbGpPWpGaD
Allopurinol—SLC22A7—Fluoropyrimidine Activity—TYMP—urinary bladder cancer	0.000964	0.0532	CbGpPWpGaD
Allopurinol—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—GSTO2—urinary bladder cancer	0.000956	0.0527	CbGpPWpGaD
Allopurinol—AOX1—lymph node—urinary bladder cancer	0.000917	0.0239	CbGeAlD
Allopurinol—SLC22A7—Fluoropyrimidine Activity—RRM2—urinary bladder cancer	0.000753	0.0415	CbGpPWpGaD
Allopurinol—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—SLC19A1—urinary bladder cancer	0.000744	0.041	CbGpPWpGaD
Allopurinol—XDH—Oxidative Stress—NQO1—urinary bladder cancer	0.000736	0.0406	CbGpPWpGaD
Allopurinol—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—PRSS3—urinary bladder cancer	0.000725	0.04	CbGpPWpGaD
Allopurinol—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	0.000672	0.0371	CbGpPWpGaD
Allopurinol—XDH—Nucleotide metabolism—TYMP—urinary bladder cancer	0.000588	0.0324	CbGpPWpGaD
Allopurinol—XDH—Oxidative Stress—SOD2—urinary bladder cancer	0.000566	0.0312	CbGpPWpGaD
Allopurinol—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	0.000565	0.0312	CbGpPWpGaD
Allopurinol—XDH—Oxidative Stress—GPX1—urinary bladder cancer	0.00054	0.0298	CbGpPWpGaD
Allopurinol—XDH—Purine metabolism—GPX1—urinary bladder cancer	0.0005	0.0276	CbGpPWpGaD
Allopurinol—XDH—Nucleotide metabolism—RRM2—urinary bladder cancer	0.000459	0.0253	CbGpPWpGaD
Allopurinol—SLC22A7—Fluoropyrimidine Activity—TYMS—urinary bladder cancer	0.000436	0.024	CbGpPWpGaD
Allopurinol—SLC22A7—Fluoropyrimidine Activity—ERCC2—urinary bladder cancer	0.000405	0.0223	CbGpPWpGaD
Allopurinol—XDH—Selenium Micronutrient Network—MPO—urinary bladder cancer	0.000381	0.021	CbGpPWpGaD
Allopurinol—SLC22A7—Fluoropyrimidine Activity—MTHFR—urinary bladder cancer	0.000381	0.021	CbGpPWpGaD
Allopurinol—SLC22A7—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000305	0.0168	CbGpPWpGaD
Allopurinol—XDH—Nucleotide metabolism—TYMS—urinary bladder cancer	0.000266	0.0146	CbGpPWpGaD
Allopurinol—SLC22A8—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000257	0.0142	CbGpPWpGaD
Allopurinol—XDH—Nucleotide metabolism—GPX1—urinary bladder cancer	0.000251	0.0139	CbGpPWpGaD
Allopurinol—XDH—Selenium Micronutrient Network—SOD2—urinary bladder cancer	0.000239	0.0132	CbGpPWpGaD
Allopurinol—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—urinary bladder cancer	0.000229	0.0126	CbGpPWpGaD
Allopurinol—XDH—Selenium Micronutrient Network—GPX1—urinary bladder cancer	0.000228	0.0126	CbGpPWpGaD
Allopurinol—XDH—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	0.000211	0.0116	CbGpPWpGaD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000155	0.00856	CbGpPWpGaD
Allopurinol—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—urinary bladder cancer	0.000146	0.00805	CbGpPWpGaD
Allopurinol—SLC22A7—Fluoropyrimidine Activity—TP53—urinary bladder cancer	0.000145	0.00797	CbGpPWpGaD
Allopurinol—XDH—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	0.000134	0.00741	CbGpPWpGaD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.00013	0.00719	CbGpPWpGaD
Allopurinol—AOX1—Disease—GSTO2—urinary bladder cancer	0.000113	0.00624	CbGpPWpGaD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000112	0.00619	CbGpPWpGaD
Allopurinol—Sweating—Epirubicin—urinary bladder cancer	0.00011	0.000486	CcSEcCtD
Allopurinol—Asthenia—Gemcitabine—urinary bladder cancer	0.00011	0.000484	CcSEcCtD
Allopurinol—Haematuria—Epirubicin—urinary bladder cancer	0.00011	0.000483	CcSEcCtD
Allopurinol—Pharyngitis—Methotrexate—urinary bladder cancer	0.000109	0.000482	CcSEcCtD
Allopurinol—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000109	0.00048	CcSEcCtD
Allopurinol—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000109	0.000479	CcSEcCtD
Allopurinol—Weight increased—Doxorubicin—urinary bladder cancer	0.000109	0.000479	CcSEcCtD
Allopurinol—Epistaxis—Epirubicin—urinary bladder cancer	0.000108	0.000478	CcSEcCtD
Allopurinol—Pruritus—Gemcitabine—urinary bladder cancer	0.000108	0.000478	CcSEcCtD
Allopurinol—Nausea—Thiotepa—urinary bladder cancer	0.000108	0.000477	CcSEcCtD
Allopurinol—Urethral disorder—Methotrexate—urinary bladder cancer	0.000108	0.000476	CcSEcCtD
Allopurinol—Feeling abnormal—Etoposide—urinary bladder cancer	0.000108	0.000475	CcSEcCtD
Allopurinol—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000108	0.000474	CcSEcCtD
Allopurinol—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000107	0.000473	CcSEcCtD
Allopurinol—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000107	0.000471	CcSEcCtD
Allopurinol—Pruritus—Fluorouracil—urinary bladder cancer	0.000107	0.00047	CcSEcCtD
Allopurinol—Drowsiness—Doxorubicin—urinary bladder cancer	0.000106	0.000469	CcSEcCtD
Allopurinol—Visual impairment—Methotrexate—urinary bladder cancer	0.000106	0.000468	CcSEcCtD
Allopurinol—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000105	0.000465	CcSEcCtD
Allopurinol—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000105	0.000464	CcSEcCtD
Allopurinol—Bradycardia—Epirubicin—urinary bladder cancer	0.000105	0.000463	CcSEcCtD
Allopurinol—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000105	0.000462	CcSEcCtD
Allopurinol—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000104	0.00046	CcSEcCtD
Allopurinol—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000104	0.00046	CcSEcCtD
Allopurinol—Urticaria—Etoposide—urinary bladder cancer	0.000104	0.000458	CcSEcCtD
Allopurinol—Haemoglobin—Epirubicin—urinary bladder cancer	0.000104	0.000457	CcSEcCtD
Allopurinol—Stomatitis—Doxorubicin—urinary bladder cancer	0.000104	0.000457	CcSEcCtD
Allopurinol—Jaundice—Doxorubicin—urinary bladder cancer	0.000104	0.000457	CcSEcCtD
Allopurinol—Rhinitis—Epirubicin—urinary bladder cancer	0.000103	0.000456	CcSEcCtD
Allopurinol—Body temperature increased—Etoposide—urinary bladder cancer	0.000103	0.000456	CcSEcCtD
Allopurinol—Abdominal pain—Etoposide—urinary bladder cancer	0.000103	0.000456	CcSEcCtD
Allopurinol—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000103	0.000456	CcSEcCtD
Allopurinol—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000103	0.000456	CcSEcCtD
Allopurinol—Hepatitis—Epirubicin—urinary bladder cancer	0.000103	0.000455	CcSEcCtD
Allopurinol—Haemorrhage—Epirubicin—urinary bladder cancer	0.000103	0.000455	CcSEcCtD
Allopurinol—Eye disorder—Methotrexate—urinary bladder cancer	0.000103	0.000454	CcSEcCtD
Allopurinol—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000103	0.000454	CcSEcCtD
Allopurinol—Tinnitus—Methotrexate—urinary bladder cancer	0.000103	0.000453	CcSEcCtD
Allopurinol—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000103	0.000453	CcSEcCtD
Allopurinol—Asthenia—Cisplatin—urinary bladder cancer	0.000102	0.000451	CcSEcCtD
Allopurinol—Pharyngitis—Epirubicin—urinary bladder cancer	0.000102	0.000451	CcSEcCtD
Allopurinol—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000102	0.000451	CcSEcCtD
Allopurinol—Sweating—Doxorubicin—urinary bladder cancer	0.000102	0.000449	CcSEcCtD
Allopurinol—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000102	0.000449	CcSEcCtD
Allopurinol—Haematuria—Doxorubicin—urinary bladder cancer	0.000101	0.000447	CcSEcCtD
Allopurinol—Urethral disorder—Epirubicin—urinary bladder cancer	0.000101	0.000446	CcSEcCtD
Allopurinol—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000101	0.000443	CcSEcCtD
Allopurinol—Epistaxis—Doxorubicin—urinary bladder cancer	0.0001	0.000442	CcSEcCtD
Allopurinol—AOX1—Metabolism—GSTZ1—urinary bladder cancer	0.0001	0.00552	CbGpPWpGaD
Allopurinol—Immune system disorder—Methotrexate—urinary bladder cancer	9.96e-05	0.000439	CcSEcCtD
Allopurinol—Dizziness—Fluorouracil—urinary bladder cancer	9.96e-05	0.000439	CcSEcCtD
Allopurinol—Visual impairment—Epirubicin—urinary bladder cancer	9.94e-05	0.000438	CcSEcCtD
Allopurinol—Agranulocytosis—Doxorubicin—urinary bladder cancer	9.93e-05	0.000438	CcSEcCtD
Allopurinol—Chills—Methotrexate—urinary bladder cancer	9.89e-05	0.000436	CcSEcCtD
Allopurinol—Diarrhoea—Cisplatin—urinary bladder cancer	9.77e-05	0.000431	CcSEcCtD
Allopurinol—Erythema multiforme—Epirubicin—urinary bladder cancer	9.76e-05	0.00043	CcSEcCtD
Allopurinol—Alopecia—Methotrexate—urinary bladder cancer	9.74e-05	0.000429	CcSEcCtD
Allopurinol—Vomiting—Gemcitabine—urinary bladder cancer	9.74e-05	0.000429	CcSEcCtD
Allopurinol—Bradycardia—Doxorubicin—urinary bladder cancer	9.72e-05	0.000428	CcSEcCtD
Allopurinol—Mental disorder—Methotrexate—urinary bladder cancer	9.66e-05	0.000426	CcSEcCtD
Allopurinol—Rash—Gemcitabine—urinary bladder cancer	9.66e-05	0.000426	CcSEcCtD
Allopurinol—Dermatitis—Gemcitabine—urinary bladder cancer	9.65e-05	0.000425	CcSEcCtD
Allopurinol—Eye disorder—Epirubicin—urinary bladder cancer	9.64e-05	0.000425	CcSEcCtD
Allopurinol—Hypersensitivity—Etoposide—urinary bladder cancer	9.64e-05	0.000425	CcSEcCtD
Allopurinol—Tinnitus—Epirubicin—urinary bladder cancer	9.62e-05	0.000424	CcSEcCtD
Allopurinol—Malnutrition—Methotrexate—urinary bladder cancer	9.6e-05	0.000423	CcSEcCtD
Allopurinol—Haemoglobin—Doxorubicin—urinary bladder cancer	9.6e-05	0.000423	CcSEcCtD
Allopurinol—Headache—Gemcitabine—urinary bladder cancer	9.6e-05	0.000423	CcSEcCtD
Allopurinol—Flushing—Epirubicin—urinary bladder cancer	9.58e-05	0.000422	CcSEcCtD
Allopurinol—Cardiac disorder—Epirubicin—urinary bladder cancer	9.58e-05	0.000422	CcSEcCtD
Allopurinol—Vomiting—Fluorouracil—urinary bladder cancer	9.58e-05	0.000422	CcSEcCtD
Allopurinol—Rhinitis—Doxorubicin—urinary bladder cancer	9.57e-05	0.000422	CcSEcCtD
Allopurinol—Hepatitis—Doxorubicin—urinary bladder cancer	9.55e-05	0.000421	CcSEcCtD
Allopurinol—Haemorrhage—Doxorubicin—urinary bladder cancer	9.55e-05	0.000421	CcSEcCtD
Allopurinol—Hypoaesthesia—Doxorubicin—urinary bladder cancer	9.5e-05	0.000419	CcSEcCtD
Allopurinol—Rash—Fluorouracil—urinary bladder cancer	9.5e-05	0.000419	CcSEcCtD
Allopurinol—Dermatitis—Fluorouracil—urinary bladder cancer	9.49e-05	0.000418	CcSEcCtD
Allopurinol—AOX1—Metabolism—NAT1—urinary bladder cancer	9.48e-05	0.00523	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—GSTO2—urinary bladder cancer	9.48e-05	0.00523	CbGpPWpGaD
Allopurinol—Pharyngitis—Doxorubicin—urinary bladder cancer	9.48e-05	0.000418	CcSEcCtD
Allopurinol—Headache—Fluorouracil—urinary bladder cancer	9.43e-05	0.000416	CcSEcCtD
Allopurinol—Urinary tract disorder—Doxorubicin—urinary bladder cancer	9.43e-05	0.000416	CcSEcCtD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	9.43e-05	0.0052	CbGpPWpGaD
Allopurinol—Dysgeusia—Methotrexate—urinary bladder cancer	9.4e-05	0.000414	CcSEcCtD
Allopurinol—Asthenia—Etoposide—urinary bladder cancer	9.38e-05	0.000414	CcSEcCtD
Allopurinol—Urethral disorder—Doxorubicin—urinary bladder cancer	9.36e-05	0.000413	CcSEcCtD
Allopurinol—Immune system disorder—Epirubicin—urinary bladder cancer	9.32e-05	0.000411	CcSEcCtD
Allopurinol—XDH—Metabolism—GSTZ1—urinary bladder cancer	9.29e-05	0.00513	CbGpPWpGaD
Allopurinol—Chills—Epirubicin—urinary bladder cancer	9.26e-05	0.000408	CcSEcCtD
Allopurinol—Pruritus—Etoposide—urinary bladder cancer	9.25e-05	0.000408	CcSEcCtD
Allopurinol—Visual impairment—Doxorubicin—urinary bladder cancer	9.2e-05	0.000406	CcSEcCtD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	9.14e-05	0.00504	CbGpPWpGaD
Allopurinol—Alopecia—Epirubicin—urinary bladder cancer	9.12e-05	0.000402	CcSEcCtD
Allopurinol—Nausea—Gemcitabine—urinary bladder cancer	9.1e-05	0.000401	CcSEcCtD
Allopurinol—Vomiting—Cisplatin—urinary bladder cancer	9.08e-05	0.0004	CcSEcCtD
Allopurinol—XDH—Selenium Micronutrient Network—TNF—urinary bladder cancer	9.07e-05	0.005	CbGpPWpGaD
Allopurinol—Mental disorder—Epirubicin—urinary bladder cancer	9.04e-05	0.000398	CcSEcCtD
Allopurinol—Erythema multiforme—Doxorubicin—urinary bladder cancer	9.03e-05	0.000398	CcSEcCtD
Allopurinol—Rash—Cisplatin—urinary bladder cancer	9e-05	0.000397	CcSEcCtD
Allopurinol—Dermatitis—Cisplatin—urinary bladder cancer	8.99e-05	0.000396	CcSEcCtD
Allopurinol—Malnutrition—Epirubicin—urinary bladder cancer	8.98e-05	0.000396	CcSEcCtD
Allopurinol—Diarrhoea—Etoposide—urinary bladder cancer	8.95e-05	0.000394	CcSEcCtD
Allopurinol—Nausea—Fluorouracil—urinary bladder cancer	8.95e-05	0.000394	CcSEcCtD
Allopurinol—Eye disorder—Doxorubicin—urinary bladder cancer	8.92e-05	0.000393	CcSEcCtD
Allopurinol—Ill-defined disorder—Methotrexate—urinary bladder cancer	8.91e-05	0.000393	CcSEcCtD
Allopurinol—Tinnitus—Doxorubicin—urinary bladder cancer	8.9e-05	0.000392	CcSEcCtD
Allopurinol—Anaemia—Methotrexate—urinary bladder cancer	8.87e-05	0.000391	CcSEcCtD
Allopurinol—Flushing—Doxorubicin—urinary bladder cancer	8.86e-05	0.000391	CcSEcCtD
Allopurinol—Cardiac disorder—Doxorubicin—urinary bladder cancer	8.86e-05	0.000391	CcSEcCtD
Allopurinol—Flatulence—Epirubicin—urinary bladder cancer	8.85e-05	0.00039	CcSEcCtD
Allopurinol—XDH—Metabolism—GSTO2—urinary bladder cancer	8.81e-05	0.00486	CbGpPWpGaD
Allopurinol—XDH—Metabolism—NAT1—urinary bladder cancer	8.81e-05	0.00486	CbGpPWpGaD
Allopurinol—AOX1—Disease—SLC19A1—urinary bladder cancer	8.8e-05	0.00486	CbGpPWpGaD
Allopurinol—Dysgeusia—Epirubicin—urinary bladder cancer	8.8e-05	0.000388	CcSEcCtD
Allopurinol—AOX1—Metabolism—UGT2B7—urinary bladder cancer	8.67e-05	0.00478	CbGpPWpGaD
Allopurinol—Malaise—Methotrexate—urinary bladder cancer	8.66e-05	0.000382	CcSEcCtD
Allopurinol—Dizziness—Etoposide—urinary bladder cancer	8.65e-05	0.000381	CcSEcCtD
Allopurinol—Immune system disorder—Doxorubicin—urinary bladder cancer	8.62e-05	0.00038	CcSEcCtD
Allopurinol—Vertigo—Methotrexate—urinary bladder cancer	8.62e-05	0.00038	CcSEcCtD
Allopurinol—Leukopenia—Methotrexate—urinary bladder cancer	8.59e-05	0.000379	CcSEcCtD
Allopurinol—AOX1—Disease—PRSS3—urinary bladder cancer	8.58e-05	0.00473	CbGpPWpGaD
Allopurinol—Chills—Doxorubicin—urinary bladder cancer	8.57e-05	0.000378	CcSEcCtD
Allopurinol—Nausea—Cisplatin—urinary bladder cancer	8.48e-05	0.000374	CcSEcCtD
Allopurinol—Alopecia—Doxorubicin—urinary bladder cancer	8.44e-05	0.000372	CcSEcCtD
Allopurinol—Mental disorder—Doxorubicin—urinary bladder cancer	8.37e-05	0.000369	CcSEcCtD
Allopurinol—Ill-defined disorder—Epirubicin—urinary bladder cancer	8.33e-05	0.000367	CcSEcCtD
Allopurinol—Convulsion—Methotrexate—urinary bladder cancer	8.32e-05	0.000367	CcSEcCtD
Allopurinol—Vomiting—Etoposide—urinary bladder cancer	8.32e-05	0.000367	CcSEcCtD
Allopurinol—Malnutrition—Doxorubicin—urinary bladder cancer	8.31e-05	0.000366	CcSEcCtD
Allopurinol—Anaemia—Epirubicin—urinary bladder cancer	8.3e-05	0.000366	CcSEcCtD
Allopurinol—Agitation—Epirubicin—urinary bladder cancer	8.26e-05	0.000364	CcSEcCtD
Allopurinol—Rash—Etoposide—urinary bladder cancer	8.25e-05	0.000363	CcSEcCtD
Allopurinol—Dermatitis—Etoposide—urinary bladder cancer	8.24e-05	0.000363	CcSEcCtD
Allopurinol—Headache—Etoposide—urinary bladder cancer	8.19e-05	0.000361	CcSEcCtD
Allopurinol—Flatulence—Doxorubicin—urinary bladder cancer	8.19e-05	0.000361	CcSEcCtD
Allopurinol—AOX1—Disease—HDAC4—urinary bladder cancer	8.18e-05	0.00451	CbGpPWpGaD
Allopurinol—Arthralgia—Methotrexate—urinary bladder cancer	8.17e-05	0.00036	CcSEcCtD
Allopurinol—Myalgia—Methotrexate—urinary bladder cancer	8.17e-05	0.00036	CcSEcCtD
Allopurinol—Dysgeusia—Doxorubicin—urinary bladder cancer	8.14e-05	0.000359	CcSEcCtD
Allopurinol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	8.12e-05	0.000358	CcSEcCtD
Allopurinol—Malaise—Epirubicin—urinary bladder cancer	8.1e-05	0.000357	CcSEcCtD
Allopurinol—Discomfort—Methotrexate—urinary bladder cancer	8.07e-05	0.000356	CcSEcCtD
Allopurinol—Vertigo—Epirubicin—urinary bladder cancer	8.07e-05	0.000356	CcSEcCtD
Allopurinol—XDH—Metabolism—UGT2B7—urinary bladder cancer	8.06e-05	0.00445	CbGpPWpGaD
Allopurinol—Leukopenia—Epirubicin—urinary bladder cancer	8.04e-05	0.000354	CcSEcCtD
Allopurinol—Confusional state—Methotrexate—urinary bladder cancer	7.9e-05	0.000348	CcSEcCtD
Allopurinol—Anaphylactic shock—Methotrexate—urinary bladder cancer	7.83e-05	0.000345	CcSEcCtD
Allopurinol—AOX1—Metabolism—CYP4B1—urinary bladder cancer	7.8e-05	0.00431	CbGpPWpGaD
Allopurinol—Convulsion—Epirubicin—urinary bladder cancer	7.78e-05	0.000343	CcSEcCtD
Allopurinol—Infection—Methotrexate—urinary bladder cancer	7.78e-05	0.000343	CcSEcCtD
Allopurinol—Nausea—Etoposide—urinary bladder cancer	7.77e-05	0.000342	CcSEcCtD
Allopurinol—Hypertension—Epirubicin—urinary bladder cancer	7.76e-05	0.000342	CcSEcCtD
Allopurinol—Ill-defined disorder—Doxorubicin—urinary bladder cancer	7.71e-05	0.00034	CcSEcCtD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	7.69e-05	0.00424	CbGpPWpGaD
Allopurinol—Nervous system disorder—Methotrexate—urinary bladder cancer	7.68e-05	0.000339	CcSEcCtD
Allopurinol—Anaemia—Doxorubicin—urinary bladder cancer	7.68e-05	0.000339	CcSEcCtD
Allopurinol—Thrombocytopenia—Methotrexate—urinary bladder cancer	7.67e-05	0.000338	CcSEcCtD
Allopurinol—Arthralgia—Epirubicin—urinary bladder cancer	7.65e-05	0.000337	CcSEcCtD
Allopurinol—Myalgia—Epirubicin—urinary bladder cancer	7.65e-05	0.000337	CcSEcCtD
Allopurinol—Agitation—Doxorubicin—urinary bladder cancer	7.64e-05	0.000337	CcSEcCtD
Allopurinol—Skin disorder—Methotrexate—urinary bladder cancer	7.61e-05	0.000335	CcSEcCtD
Allopurinol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	7.6e-05	0.000335	CcSEcCtD
Allopurinol—Hyperhidrosis—Methotrexate—urinary bladder cancer	7.57e-05	0.000334	CcSEcCtD
Allopurinol—Discomfort—Epirubicin—urinary bladder cancer	7.56e-05	0.000333	CcSEcCtD
Allopurinol—Malaise—Doxorubicin—urinary bladder cancer	7.5e-05	0.00033	CcSEcCtD
Allopurinol—Vertigo—Doxorubicin—urinary bladder cancer	7.47e-05	0.000329	CcSEcCtD
Allopurinol—Anorexia—Methotrexate—urinary bladder cancer	7.47e-05	0.000329	CcSEcCtD
Allopurinol—Leukopenia—Doxorubicin—urinary bladder cancer	7.44e-05	0.000328	CcSEcCtD
Allopurinol—Confusional state—Epirubicin—urinary bladder cancer	7.39e-05	0.000326	CcSEcCtD
Allopurinol—AOX1—Metabolism—SLC19A1—urinary bladder cancer	7.37e-05	0.00407	CbGpPWpGaD
Allopurinol—Anaphylactic shock—Epirubicin—urinary bladder cancer	7.33e-05	0.000323	CcSEcCtD
Allopurinol—Oedema—Epirubicin—urinary bladder cancer	7.33e-05	0.000323	CcSEcCtD
Allopurinol—Hypotension—Methotrexate—urinary bladder cancer	7.32e-05	0.000323	CcSEcCtD
Allopurinol—Infection—Epirubicin—urinary bladder cancer	7.28e-05	0.000321	CcSEcCtD
Allopurinol—XDH—Metabolism—CYP4B1—urinary bladder cancer	7.26e-05	0.004	CbGpPWpGaD
Allopurinol—Convulsion—Doxorubicin—urinary bladder cancer	7.2e-05	0.000317	CcSEcCtD
Allopurinol—Nervous system disorder—Epirubicin—urinary bladder cancer	7.19e-05	0.000317	CcSEcCtD
Allopurinol—AOX1—Metabolism—PRSS3—urinary bladder cancer	7.18e-05	0.00396	CbGpPWpGaD
Allopurinol—Thrombocytopenia—Epirubicin—urinary bladder cancer	7.18e-05	0.000316	CcSEcCtD
Allopurinol—Hypertension—Doxorubicin—urinary bladder cancer	7.18e-05	0.000316	CcSEcCtD
Allopurinol—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	7.14e-05	0.000315	CcSEcCtD
Allopurinol—Skin disorder—Epirubicin—urinary bladder cancer	7.12e-05	0.000314	CcSEcCtD
Allopurinol—Hyperhidrosis—Epirubicin—urinary bladder cancer	7.09e-05	0.000312	CcSEcCtD
Allopurinol—Insomnia—Methotrexate—urinary bladder cancer	7.09e-05	0.000312	CcSEcCtD
Allopurinol—Arthralgia—Doxorubicin—urinary bladder cancer	7.08e-05	0.000312	CcSEcCtD
Allopurinol—Myalgia—Doxorubicin—urinary bladder cancer	7.08e-05	0.000312	CcSEcCtD
Allopurinol—Paraesthesia—Methotrexate—urinary bladder cancer	7.03e-05	0.00031	CcSEcCtD
Allopurinol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	7.03e-05	0.00031	CcSEcCtD
Allopurinol—Discomfort—Doxorubicin—urinary bladder cancer	6.99e-05	0.000308	CcSEcCtD
Allopurinol—Anorexia—Epirubicin—urinary bladder cancer	6.99e-05	0.000308	CcSEcCtD
Allopurinol—Somnolence—Methotrexate—urinary bladder cancer	6.96e-05	0.000307	CcSEcCtD
Allopurinol—Dyspepsia—Methotrexate—urinary bladder cancer	6.9e-05	0.000304	CcSEcCtD
Allopurinol—XDH—Metabolism—SLC19A1—urinary bladder cancer	6.85e-05	0.00378	CbGpPWpGaD
Allopurinol—Hypotension—Epirubicin—urinary bladder cancer	6.85e-05	0.000302	CcSEcCtD
Allopurinol—Confusional state—Doxorubicin—urinary bladder cancer	6.84e-05	0.000301	CcSEcCtD
Allopurinol—Decreased appetite—Methotrexate—urinary bladder cancer	6.81e-05	0.0003	CcSEcCtD
Allopurinol—Oedema—Doxorubicin—urinary bladder cancer	6.78e-05	0.000299	CcSEcCtD
Allopurinol—Anaphylactic shock—Doxorubicin—urinary bladder cancer	6.78e-05	0.000299	CcSEcCtD
Allopurinol—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	6.76e-05	0.000298	CcSEcCtD
Allopurinol—Infection—Doxorubicin—urinary bladder cancer	6.74e-05	0.000297	CcSEcCtD
Allopurinol—Pain—Methotrexate—urinary bladder cancer	6.7e-05	0.000295	CcSEcCtD
Allopurinol—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	6.68e-05	0.000294	CcSEcCtD
Allopurinol—XDH—Metabolism—PRSS3—urinary bladder cancer	6.68e-05	0.00368	CbGpPWpGaD
Allopurinol—Nervous system disorder—Doxorubicin—urinary bladder cancer	6.65e-05	0.000293	CcSEcCtD
Allopurinol—Thrombocytopenia—Doxorubicin—urinary bladder cancer	6.64e-05	0.000293	CcSEcCtD
Allopurinol—Insomnia—Epirubicin—urinary bladder cancer	6.63e-05	0.000292	CcSEcCtD
Allopurinol—Skin disorder—Doxorubicin—urinary bladder cancer	6.59e-05	0.00029	CcSEcCtD
Allopurinol—Paraesthesia—Epirubicin—urinary bladder cancer	6.58e-05	0.00029	CcSEcCtD
Allopurinol—Hyperhidrosis—Doxorubicin—urinary bladder cancer	6.56e-05	0.000289	CcSEcCtD
Allopurinol—Somnolence—Epirubicin—urinary bladder cancer	6.52e-05	0.000287	CcSEcCtD
Allopurinol—AOX1—Disease—LIG1—urinary bladder cancer	6.5e-05	0.00359	CbGpPWpGaD
Allopurinol—Anorexia—Doxorubicin—urinary bladder cancer	6.47e-05	0.000285	CcSEcCtD
Allopurinol—Feeling abnormal—Methotrexate—urinary bladder cancer	6.46e-05	0.000285	CcSEcCtD
Allopurinol—Dyspepsia—Epirubicin—urinary bladder cancer	6.45e-05	0.000284	CcSEcCtD
Allopurinol—Gastrointestinal pain—Methotrexate—urinary bladder cancer	6.41e-05	0.000282	CcSEcCtD
Allopurinol—Decreased appetite—Epirubicin—urinary bladder cancer	6.37e-05	0.000281	CcSEcCtD
Allopurinol—Hypotension—Doxorubicin—urinary bladder cancer	6.34e-05	0.000279	CcSEcCtD
Allopurinol—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	6.33e-05	0.000279	CcSEcCtD
Allopurinol—Pain—Epirubicin—urinary bladder cancer	6.27e-05	0.000276	CcSEcCtD
Allopurinol—Constipation—Epirubicin—urinary bladder cancer	6.27e-05	0.000276	CcSEcCtD
Allopurinol—Urticaria—Methotrexate—urinary bladder cancer	6.22e-05	0.000274	CcSEcCtD
Allopurinol—Abdominal pain—Methotrexate—urinary bladder cancer	6.19e-05	0.000273	CcSEcCtD
Allopurinol—Body temperature increased—Methotrexate—urinary bladder cancer	6.19e-05	0.000273	CcSEcCtD
Allopurinol—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	6.18e-05	0.000272	CcSEcCtD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	6.18e-05	0.00341	CbGpPWpGaD
Allopurinol—Insomnia—Doxorubicin—urinary bladder cancer	6.14e-05	0.00027	CcSEcCtD
Allopurinol—Paraesthesia—Doxorubicin—urinary bladder cancer	6.09e-05	0.000268	CcSEcCtD
Allopurinol—Feeling abnormal—Epirubicin—urinary bladder cancer	6.04e-05	0.000266	CcSEcCtD
Allopurinol—Somnolence—Doxorubicin—urinary bladder cancer	6.03e-05	0.000266	CcSEcCtD
Allopurinol—Gastrointestinal pain—Epirubicin—urinary bladder cancer	6e-05	0.000264	CcSEcCtD
Allopurinol—Dyspepsia—Doxorubicin—urinary bladder cancer	5.97e-05	0.000263	CcSEcCtD
Allopurinol—Decreased appetite—Doxorubicin—urinary bladder cancer	5.9e-05	0.00026	CcSEcCtD
Allopurinol—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	5.86e-05	0.000258	CcSEcCtD
Allopurinol—Urticaria—Epirubicin—urinary bladder cancer	5.82e-05	0.000257	CcSEcCtD
Allopurinol—Pain—Doxorubicin—urinary bladder cancer	5.8e-05	0.000256	CcSEcCtD
Allopurinol—Constipation—Doxorubicin—urinary bladder cancer	5.8e-05	0.000256	CcSEcCtD
Allopurinol—Abdominal pain—Epirubicin—urinary bladder cancer	5.8e-05	0.000255	CcSEcCtD
Allopurinol—Body temperature increased—Epirubicin—urinary bladder cancer	5.8e-05	0.000255	CcSEcCtD
Allopurinol—Hypersensitivity—Methotrexate—urinary bladder cancer	5.77e-05	0.000254	CcSEcCtD
Allopurinol—AOX1—Metabolism—TYMP—urinary bladder cancer	5.74e-05	0.00317	CbGpPWpGaD
Allopurinol—Asthenia—Methotrexate—urinary bladder cancer	5.62e-05	0.000248	CcSEcCtD
Allopurinol—Feeling abnormal—Doxorubicin—urinary bladder cancer	5.59e-05	0.000246	CcSEcCtD
Allopurinol—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	5.55e-05	0.000245	CcSEcCtD
Allopurinol—Pruritus—Methotrexate—urinary bladder cancer	5.54e-05	0.000244	CcSEcCtD
Allopurinol—Hypersensitivity—Epirubicin—urinary bladder cancer	5.4e-05	0.000238	CcSEcCtD
Allopurinol—Urticaria—Doxorubicin—urinary bladder cancer	5.39e-05	0.000238	CcSEcCtD
Allopurinol—Abdominal pain—Doxorubicin—urinary bladder cancer	5.36e-05	0.000236	CcSEcCtD
Allopurinol—Body temperature increased—Doxorubicin—urinary bladder cancer	5.36e-05	0.000236	CcSEcCtD
Allopurinol—Diarrhoea—Methotrexate—urinary bladder cancer	5.36e-05	0.000236	CcSEcCtD
Allopurinol—XDH—Metabolism—TYMP—urinary bladder cancer	5.34e-05	0.00294	CbGpPWpGaD
Allopurinol—Asthenia—Epirubicin—urinary bladder cancer	5.26e-05	0.000232	CcSEcCtD
Allopurinol—AOX1—Metabolism—NAT2—urinary bladder cancer	5.19e-05	0.00286	CbGpPWpGaD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	5.19e-05	0.00286	CbGpPWpGaD
Allopurinol—Pruritus—Epirubicin—urinary bladder cancer	5.19e-05	0.000229	CcSEcCtD
Allopurinol—Dizziness—Methotrexate—urinary bladder cancer	5.18e-05	0.000228	CcSEcCtD
Allopurinol—Diarrhoea—Epirubicin—urinary bladder cancer	5.02e-05	0.000221	CcSEcCtD
Allopurinol—Hypersensitivity—Doxorubicin—urinary bladder cancer	5e-05	0.00022	CcSEcCtD
Allopurinol—Vomiting—Methotrexate—urinary bladder cancer	4.98e-05	0.00022	CcSEcCtD
Allopurinol—AOX1—Disease—ENO2—urinary bladder cancer	4.96e-05	0.00273	CbGpPWpGaD
Allopurinol—Rash—Methotrexate—urinary bladder cancer	4.94e-05	0.000218	CcSEcCtD
Allopurinol—Dermatitis—Methotrexate—urinary bladder cancer	4.94e-05	0.000218	CcSEcCtD
Allopurinol—Headache—Methotrexate—urinary bladder cancer	4.91e-05	0.000216	CcSEcCtD
Allopurinol—Asthenia—Doxorubicin—urinary bladder cancer	4.87e-05	0.000215	CcSEcCtD
Allopurinol—Dizziness—Epirubicin—urinary bladder cancer	4.85e-05	0.000214	CcSEcCtD
Allopurinol—XDH—Metabolism—NAT2—urinary bladder cancer	4.83e-05	0.00266	CbGpPWpGaD
Allopurinol—Pruritus—Doxorubicin—urinary bladder cancer	4.8e-05	0.000212	CcSEcCtD
Allopurinol—AOX1—Disease—RBX1—urinary bladder cancer	4.7e-05	0.00259	CbGpPWpGaD
Allopurinol—Vomiting—Epirubicin—urinary bladder cancer	4.66e-05	0.000205	CcSEcCtD
Allopurinol—Nausea—Methotrexate—urinary bladder cancer	4.65e-05	0.000205	CcSEcCtD
Allopurinol—Diarrhoea—Doxorubicin—urinary bladder cancer	4.64e-05	0.000205	CcSEcCtD
Allopurinol—Rash—Epirubicin—urinary bladder cancer	4.62e-05	0.000204	CcSEcCtD
Allopurinol—Dermatitis—Epirubicin—urinary bladder cancer	4.62e-05	0.000204	CcSEcCtD
Allopurinol—Headache—Epirubicin—urinary bladder cancer	4.59e-05	0.000202	CcSEcCtD
Allopurinol—Dizziness—Doxorubicin—urinary bladder cancer	4.49e-05	0.000198	CcSEcCtD
Allopurinol—AOX1—Metabolism—RRM2—urinary bladder cancer	4.48e-05	0.00247	CbGpPWpGaD
Allopurinol—Nausea—Epirubicin—urinary bladder cancer	4.35e-05	0.000192	CcSEcCtD
Allopurinol—Vomiting—Doxorubicin—urinary bladder cancer	4.31e-05	0.00019	CcSEcCtD
Allopurinol—Rash—Doxorubicin—urinary bladder cancer	4.28e-05	0.000189	CcSEcCtD
Allopurinol—Dermatitis—Doxorubicin—urinary bladder cancer	4.27e-05	0.000188	CcSEcCtD
Allopurinol—Headache—Doxorubicin—urinary bladder cancer	4.25e-05	0.000187	CcSEcCtD
Allopurinol—AOX1—Disease—JAG1—urinary bladder cancer	4.21e-05	0.00232	CbGpPWpGaD
Allopurinol—XDH—Metabolism—RRM2—urinary bladder cancer	4.17e-05	0.0023	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—ENO2—urinary bladder cancer	4.15e-05	0.00229	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—HPGDS—urinary bladder cancer	4.15e-05	0.00229	CbGpPWpGaD
Allopurinol—Nausea—Doxorubicin—urinary bladder cancer	4.03e-05	0.000178	CcSEcCtD
Allopurinol—AOX1—Metabolism—GSTT1—urinary bladder cancer	4.03e-05	0.00222	CbGpPWpGaD
Allopurinol—XDH—Metabolism—HPGDS—urinary bladder cancer	3.86e-05	0.00213	CbGpPWpGaD
Allopurinol—XDH—Metabolism—ENO2—urinary bladder cancer	3.86e-05	0.00213	CbGpPWpGaD
Allopurinol—XDH—Metabolism—GSTT1—urinary bladder cancer	3.74e-05	0.00207	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—NQO1—urinary bladder cancer	3.35e-05	0.00185	CbGpPWpGaD
Allopurinol—XDH—Metabolism—NQO1—urinary bladder cancer	3.11e-05	0.00172	CbGpPWpGaD
Allopurinol—AOX1—Disease—NCOR1—urinary bladder cancer	3.06e-05	0.00169	CbGpPWpGaD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.89e-05	0.00159	CbGpPWpGaD
Allopurinol—AOX1—Disease—ERCC2—urinary bladder cancer	2.88e-05	0.00159	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—GSTP1—urinary bladder cancer	2.79e-05	0.00154	CbGpPWpGaD
Allopurinol—AOX1—Disease—MTHFR—urinary bladder cancer	2.71e-05	0.00149	CbGpPWpGaD
Allopurinol—AOX1—Disease—TERT—urinary bladder cancer	2.7e-05	0.00149	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—TYMS—urinary bladder cancer	2.59e-05	0.00143	CbGpPWpGaD
Allopurinol—XDH—Metabolism—GSTP1—urinary bladder cancer	2.59e-05	0.00143	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—NCOR1—urinary bladder cancer	2.56e-05	0.00141	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—GSTM1—urinary bladder cancer	2.56e-05	0.00141	CbGpPWpGaD
Allopurinol—AOX1—Disease—FGFR3—urinary bladder cancer	2.48e-05	0.00137	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—GPX1—urinary bladder cancer	2.46e-05	0.00135	CbGpPWpGaD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.43e-05	0.00134	CbGpPWpGaD
Allopurinol—XDH—Metabolism—TYMS—urinary bladder cancer	2.41e-05	0.00133	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—ERCC2—urinary bladder cancer	2.41e-05	0.00133	CbGpPWpGaD
Allopurinol—XDH—Metabolism—NCOR1—urinary bladder cancer	2.38e-05	0.00132	CbGpPWpGaD
Allopurinol—XDH—Metabolism—GSTM1—urinary bladder cancer	2.38e-05	0.00132	CbGpPWpGaD
Allopurinol—XDH—Metabolism—GPX1—urinary bladder cancer	2.28e-05	0.00126	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—MTHFR—urinary bladder cancer	2.27e-05	0.00125	CbGpPWpGaD
Allopurinol—XDH—Metabolism—ERCC2—urinary bladder cancer	2.24e-05	0.00124	CbGpPWpGaD
Allopurinol—AOX1—Disease—CREBBP—urinary bladder cancer	2.11e-05	0.00116	CbGpPWpGaD
Allopurinol—XDH—Metabolism—MTHFR—urinary bladder cancer	2.11e-05	0.00116	CbGpPWpGaD
Allopurinol—AOX1—Disease—RHOA—urinary bladder cancer	1.91e-05	0.00105	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—PPARG—urinary bladder cancer	1.84e-05	0.00101	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—CREBBP—urinary bladder cancer	1.77e-05	0.000974	CbGpPWpGaD
Allopurinol—AOX1—Disease—ERBB2—urinary bladder cancer	1.77e-05	0.000974	CbGpPWpGaD
Allopurinol—AOX1—Disease—PTGS2—urinary bladder cancer	1.73e-05	0.000952	CbGpPWpGaD
Allopurinol—XDH—Metabolism—PPARG—urinary bladder cancer	1.71e-05	0.000943	CbGpPWpGaD
Allopurinol—XDH—Metabolism—CREBBP—urinary bladder cancer	1.64e-05	0.000906	CbGpPWpGaD
Allopurinol—AOX1—Disease—CDKN1A—urinary bladder cancer	1.51e-05	0.000833	CbGpPWpGaD
Allopurinol—AOX1—Disease—PTEN—urinary bladder cancer	1.51e-05	0.000831	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—PTGS2—urinary bladder cancer	1.45e-05	0.000798	CbGpPWpGaD
Allopurinol—AOX1—Disease—EP300—urinary bladder cancer	1.44e-05	0.000792	CbGpPWpGaD
Allopurinol—AOX1—Disease—SRC—urinary bladder cancer	1.4e-05	0.00077	CbGpPWpGaD
Allopurinol—XDH—Metabolism—PTGS2—urinary bladder cancer	1.34e-05	0.000742	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—PTEN—urinary bladder cancer	1.26e-05	0.000696	CbGpPWpGaD
Allopurinol—AOX1—Disease—MYC—urinary bladder cancer	1.25e-05	0.00069	CbGpPWpGaD
Allopurinol—AOX1—Disease—EGFR—urinary bladder cancer	1.22e-05	0.000675	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—EP300—urinary bladder cancer	1.2e-05	0.000663	CbGpPWpGaD
Allopurinol—XDH—Metabolism—PTEN—urinary bladder cancer	1.17e-05	0.000647	CbGpPWpGaD
Allopurinol—AOX1—Disease—KRAS—urinary bladder cancer	1.16e-05	0.000638	CbGpPWpGaD
Allopurinol—XDH—Metabolism—EP300—urinary bladder cancer	1.12e-05	0.000617	CbGpPWpGaD
Allopurinol—AOX1—Disease—HRAS—urinary bladder cancer	9.83e-06	0.000542	CbGpPWpGaD
